1. 495 Basal cell carcinoma demonstrates a T-cell exclusion immune phenotype in contrast to other anti-PD-1 therapy responsive cutaneous malignancies. (9th November 2020) Authors: Gibney, Geoffrey; Xiu, Joanne; In, Gino; O'Day, Steven; Lutzky, Jose; Drabick, Joseph; VanderWalde, Ari; Poorman, Kelsey; Korn, W; Atkins, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 495 Basal cell carcinoma demonstrates a T-cell exclusion immune phenotype in contrast to other anti-PD-1 therapy responsive cutaneous malignancies. (9th November 2020) Authors: Gibney, Geoffrey; Xiu, Joanne; In, Gino; O'Day, Steven; Lutzky, Jose; Drabick, Joseph; VanderWalde, Ari; Poorman, Kelsey; Korn, W; Atkins, Michael Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265). (4th November 2015) Authors: Long, Georgina V; Dummer, Reinhard; Ribas, Antoni; Puzanov, Igor; Michielin, Olivier; VanderWalde, Ari; Andtbacka, Robert HI; Cebon, Jonathan; Fernandez, Eugenio; Malvehy, Josep; Olszanski, Anthony J; Gajewski, Thomas F; Kirkwood, John M; Kuznetsova, Olga; Chen, Lisa; Kaufman, David R; Chou, Jeff... Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265). Issue 2 (December 2015) Authors: Long, Georgina; Dummer, Reinhard; Ribas, Antoni; Puzanov, Igor; Michielin, Olivier; VanderWalde, Ari; Andtbacka, Robert; Cebon, Jonathan; Fernandez, Eugenio; Malvehy, Josep; Olszanski, Anthony; Gajewski, Thomas; Kirkwood, John; Kuznetsova, Olga; Chen, Lisa; Kaufman, David; Chou, Jeffrey; Hodi, F Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015) Authors: Mesía, Ricard; Henke, Michael; Fortin, Andre; Minn, Heikki; Yunes Ancona, Alejandro Cesar; Cmelak, Anthony; Markowitz, Avi B; Hotte, Sebastien J; Singh, Simron; Chan, Anthony T C; Merlano, Marco C; Skladowski, Krzysztof; Zhang, Alicia; Oliner, Kelly S; VanderWalde, Ari; Giralt, Jordi Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015) Authors: Mesía, Ricard; Henke, Michael; Fortin, Andre; Minn, Heikki; Yunes Ancona, Alejandro Cesar; Cmelak, Anthony; Markowitz, Avi B; Hotte, Sebastien J; Singh, Simron; Chan, Anthony T C; Merlano, Marco C; Skladowski, Krzysztof; Zhang, Alicia; Oliner, Kelly S; VanderWalde, Ari; Giralt, Jordi Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study. (1st February 2018) Authors: Skinner, Karen E.; Fernandes, Ancilla W.; Walker, Mark S.; Pavilack, Melissa; VanderWalde, Ari Journal: Journal of medical economics Issue: Volume 21:Number 2(2018) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphoma. (17th April 2017) Authors: Martin, Peter; Chen, Zhengming; Cheson, Bruce D.; Robinson, Katherine S.; Williams, Michael; Rajguru, Saurabh A.; Friedberg, Jonathan W.; van der Jagt, Richard H.; LaCasce, Ann S.; Joyce, Robin; Ganjoo, Kristen N.; Bartlett, Nancy L.; Lemieux, Bernard; VanderWalde, Ari; Herst, Jordan; Szer, Jeffr... Journal: British journal of haematology Issue: Volume 178:Number 2(2017) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Melanoma and immunotherapy bridge 2015. Issue 1 (July 2016) Authors: Nanda, Vashisht; Peng, Weiyi; Hwu, Patrick; Davies, Michael; Ciliberto, Gennaro; Fattore, Luigi; Malpicci, Debora; Aurisicchio, Luigi; Ascierto, Paolo; Croce, Carlo; Mancini, Rita; Spranger, Stefani; Gajewski, Thomas; Wang, Yangyang; Ferrone, Soldano; Vanpouille-Box, Claire; Wennerberg, Erik; Pil... Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial. Issue 2 (February 2015) Authors: Giralt, Jordi; Trigo, Jose; Nuyts, Sandra; Ozsahin, Mahmut; Skladowski, Krzysztof; Hatoum, Georges; Daisne, Jean-Francois; Yunes Ancona, Alejandro César; Cmelak, Anthony; Mesía, Ricard; Zhang, Alicia; Oliner, Kelly S; VanderWalde, Ari Journal: Lancet oncology Issue: Volume 16:Issue 2(2015:Feb.) Page Start: 221 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗